home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Webinar On Drug Development & Discovery by FDA Standards

 
  April 15, 2015  
     
 


Compliance Trainings, Online
2015-04-27


Description :

The Drug Discovery and Development (but also the biologics and medical device) process is a very complex process with every participant focusing on their particular piece of discovery or development. You can spend a lifetime in your part of the process, without ever understanding the complete picture. While you may hear or see the other parts by interacting with colleagues from other parts of the process you never quite get the whole picture. Add to that, that different regulatory agencies have different requirements and it often feels like pieces of a jigsaw puzzle which you see at random, never quite understanding how they all fit together to get the big picture.

This leaves you confused, causes friction between departments and leaves the company prone to errors and mishaps that can be avoided if you understood what the other parts of the company and an FDA inspector require of you. This in turn results in delayed timelines, product recalls and operational inefficiencies.

This webinar will lay out the whole process systematically and in a simplified manner. It will help you to understand how what you do and your goals and objectives, contribute to the overall success of the company, both in terms of product approval by the FDA or in terms of successful inspection outcomes. At the end of the webinar, you will be able to have better communication with your functional colleagues and the quality and regulatory affairs departments. This will lead to higher quality product, easier approvals, many fewer errors and much less friction between departments. It is a must for anyone that is either joining the Pharmaceutical / Biotechnology / Medical Device industries for the first time, or anyone that is transferring from one part of the company to another part (e.g. from discovery to development and vice versa). Also for international attendees that need to familiarize themselves with the FDA process and how it differs from other regulatory authorities.

Areas Covered in the Session :

Stages of Drug Development and Review

Drug Review Steps Simplified

Reviewing Applications

Accelerated Approvals

Bumps in the Road

The Role of User Fees

The Quality of Clinical Trials

How Drugs are Approved

How does the FDA differ from other regulatory authorities

Frequently Asked Questions about the FDA Drug Approval Process

Who Will Benefit:

This is a fundamental course that will benefit the following people:

Anyone that works or plans to work in Pharmaceutical, Biotechnology or Medical Device Industries will benefit.

Anyone that is already working in the above industries, but is transferring from one part of the industry to another part (e.g. transferring from discovery to development of vice versa)

Anyone that works in companies that support the above industries e.g., IRBs, CROs, Data Monitoring Companies

International attendees that may be familiar with the above process in their country and for their regulatory authorities, but wants to learn the process as expected by the FDA

Price tags:

Live

Single Live : For One Participant

$ 249

Corporate Live : For Max. 10 Participants

$ 899

Recording

Single REC : For One Participant - Unlimited Access for 6 Months

$ 299

For more information and enquiries contact us at

Compliance Trainings

 

5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada 
Customer Support : #416-915-4458 
Email : support@compliancetrainings.com

 
 
Organized by: Compliance Trainings
Invited Speakers:

Angela Bazigos, is the CEO of Touchstone Technologies Silicon Valley, Inc. "Knowledge is Power". She has 35 years of experience in the Lifesciences industry spanning GLP, GCP, GMP, Medical Devices & 21 CFR 11 and has a patent aimed at speeding up Software Compliance.

Ms. Bazigos is a Past President of PRCSQA, a member of the SQA CVIC, ASQ, DIA and RAPS. She works closely with the FDA on behalf of her clients. She consults to LifeScience Investment Groups as well as to Pharma / Biotech / Medical Device companies on compliance matters, including strategy, submissions, quality assurance and remediations following action by the FDA.

 

More recently, Ms. Bazigos co-authored Computerized Systems in Clinical Research / Current Data Quality and Data Integrity Concepts with FDA, DIA and Academia. She was on the board for UC Berkeley's Business School for Executive Education in Life Sciences and is now on the Stanford Who's Who Registry for her contributions to the Lifesciences industry.

 
Deadline for Abstracts: 2015-04-27
 
Registration:

For more information about this event please visit

 

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1398

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.